While αvβ3 integrin-targeting frequently led to higher nanoparticle deposition than EGFR-targeting, histological analysis illustrated the significant spatial variability between the two targeting variants, suggesting that a single-ligand formulation is not capable of capturing each and every region with metastatic cancer cells. Here, EGFR is linked to metastatic malignant neoplasm.